Nortriptyline
I-compound ye-organic e-tricyclic eyi-10,11-dihydro-5H-dibenzo[a,d][7]annulene esethathelwe iqembu le-3-(methylamino)propylidene endaweni u-5. Kuyi-metabolite evuselelwe ye-amitriptyline. — ChEBI
Izimpendulo ezisheshayo mayelana no-Nortriptyline
Ukuhlonza, i-formula, umassYini u-Nortriptyline, CAS 72-69-5?
Nortriptyline yisithako esihlangene ne-CAS 72-69-5 ku-ChEBI i-entry CHEBI:7640. I-formula ekhishwe yiwu C19H21N. Qinisekisa izibonakaliso zesakhiwo lapho uqhathanisa amagayidi, ama-hydrate, ama-isomer noma izinto ezimakiwe nge-isotope.
Umthombo ↗Yini isisindo somshini sika-Nortriptyline?
Isisindo somshini esibikiwe ngu-ChEBI singu-263.384 g/mol ku-formula C19H21N. Isisindo sayo somshini esibikiwe emthombo singu-263.1674 Da; lokho kusebenzisa ukuhleleka kwe-isotope ethile futhi kuyisilinganiso esihlukile.
Umthombo ↗Iziphi izimpawu ze-PubChem ezitholakala ku-Nortriptyline?
CID 4543 ixhumene nale ncwadi ngokuhambelana kwe-InChIKey eqondile. I-PubChem ikhombisa i-exact mass 263.167399674 Da. i-computed XLogP 4.5. Izimiso nezinkomba zomthombo zikhonjiswe ngokuhlukana ematafuleni ezimpawu ngezansi.
Umthombo ↗Ukuhlonza · i-formula · umass
Izimiso ezihlobene nomthombo| Inombolo u-CAS | 72-69-5 | ChEBI ↗ |
| Ifomula yebhayisikemi | C19H21N | ChEBI ↗ |
| Umass we-molar | 263.384 g/mol | ChEBI ↗ |
| Umass we-monoisotopic | 263.1674 Da | ChEBI ↗ |
| I-formal charge | 0 | ChEBI ↗ |
| ChEBI isibonakaliso sokuhlonza | CHEBI:7640 | ChEBI ↗ |
Izimpawu zomshini ze-PubChem
PubChem| Umass we-molar | 263.4 g/mol | PubChem ↗ |
| Isisindo esiqondile | 263.167399674 Da | PubChem ↗ |
| i-XLogP ekaluliwe | 4.5 | PubChem ↗ |
| i-Topological polar surface area (Ų) | 12 | PubChem ↗ |
| Ama-H-bond donors | 1 | PubChem ↗ |
| Ama-H-bond acceptors | 1 | PubChem ↗ |
| Ama-bonds angavuthululwa | 3 | PubChem ↗ |
Izilinganiso ezibaliswe yi-PubChem zikhonjiswa ngokuhlukile kurekhodi lika-ChEBI. Ukuhambisana kwe-InChIKey okuqondile kwasetshenziswa ukuxhumanisa amarekhodi. Izincazelo zomshini azichazi ukuhlanzeka komkhiqizo onikeziwe, usayizi wamaph粒子 noma ukusebenza.
Amagama nezibonakaliso zesakhiwo
Kopisha noma iyiphi imibhalo yokuhlonzanortriptyline3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-aminePHVGLTMQBUFIQQ-UHFFFAOYSA-NCNCCC=C1c2ccccc2CCc2ccccc21InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3Amagama nezihumusho
Amagama anikezwa ngu-ChEBI. Amagama emakethe nezihumusho ezihlobene angachaza umongo womkhiqizo omkhulu.
Ukuhlukaniswa nobudlelwano
ChEBI ontologyImisebenzi ebekwe ku-ChEBI
Izincazelo zemisebenzi yedathabhulethi zichaza imisebenzi yobomi noma yenkhemikhali ebekiwe; aziyona ukunikezwa kwamukelwa kwemikhiqizo noma izincomo zokusebenzisa.
Imibhalo nezinkomba zokuphepha
Ukuhambelana komthengisi kubalulekileThola idokumentsi lobuphepho lomthengisi wakho othile, inombolo yomkhiqizo kanye ne-grade.
Thola SDS ekhethekile kumkhiqizo
Izihlobo zokuphepha nemibhalo yokuhlukaniswa kahle yuhulumeni akuyona SDS yomkhiqizi. Qinisekisa umthengisi, inombolo yomkhiqizo, ukusetshenziswa, isimo somzimba, isifunda kanye nokubuyekeza ngaphambi kokusebenzisa umbhalo.
Umass ↔ inani lesisindo
Kukhiwe kusetshenziswa umass otholakeleIsebenzisa u-263.384 g/mol kusuka ku-ChEBI; isisekelo: isithako nefomula ekhonjiswe kurekhodi lolu. Akukho kulungiswa kokuhlanzeka noma kokugxila okwenziwayo.
Ukuhleleka kwezinto ezisemayelana nezinto ezakha umshini
Izilinganiso zomshini ezibaliswe ngokwemibonoCHNIzilinganiso zomshini ezibaliswe kusuka ku-formula ebekiwe nasezintweni zezintambo ze-PubChem. Lezi akuzona imiphumela yokuhlola noma yokuhlanzeka.
Izinkomba zobucwaningo nezipatenti
Ukuhlobana kwemithombo ekhethiweImithombo nomlando wombhalo
Kuhloliwe 27 Septhemba 2026Khishwa ngo-255, 9 Septhemba 2026. ChEBI isigaba somthombo esinezinwele ezintathu (esichazwe ngesandla). Buka irekhodi lokuqala ↗ · CC BY 4.0
I-PubCAS ihlela idatha yomthombo, ixhumanisa izinkomba futhi ibale ukuguquka okubhalwe ngokucacile. Ama-cross-reference ka-CAS anikezwa ngu-ChEBI; awazi ukunwetshwa noma ukusekelwa kwe-CAS.